How African American Adolescents Manage Depression: Being With Others

BACKGROUND: African American (AA) adolescents with depression face serious negative outcomes. Despite racial/ethnic disparities in treatment utilization, few studies have explored how AA adolescents manage their depression. OBJECTIVE: To describe common ways AA adolescents manage depressive symptoms through relationships with people in their lives. DESIGN: Qualitative descriptive methods were used to analyze the narratives of 22 AA young adults who had been depressed as adolescents and 5 AA adolescents in treatment for depression. RESULTS: A typology describing the varied ways AA adolescents manage their depressive symptoms through interactions with other people was constructed and labeled Being With Others. The five categories in the typology are keeping others at bay, striking out at others, seeking help from others, joining in with others, and having others reach out CONCLUSIONS: Clinicians might use the Being With Others typology to guide discussions related to detecting, assessing, and treating AA adolescents with depression

Experiences and Perceptions of Depression in Young Black Men after Incarceration

Title from PDF of title page, viewed on March 31, 2014Dissertation advisor: Patricia J. KellyVitaIncludes bibliographical references (pages 94-101)Thesis (Ph. D.)--School of Nursing and Health Studies. University of Missouri--Kansas City, 2013One in three Black men in the U.S. faces difficulties obtaining employment, housing and maintaining self-sufficiency post incarceration. Felony records result in considerable social and economic vulnerability, which place many young Black men at risk for depression. However, very little is known about depression in young Black men or how depression is experienced and perceived by those with a felony record. Further, cultural and gender divergences from traditional clinical definitions and symptomatology of depression can complicate accurate and efficient identification of depression in these young men. Therefore, the purpose of this research was 1) to explore experiences and perceptions of depression in young Black men who have a history of incarceration and 2) to explore the social consequences of depression in this population. Semi-structured interviews were conducted with twenty Black men who have a history of incarceration to explore individual perceptions and experiences of depression. Data were analyzed using an inductive process and thematic analysis. Emergent themes for individual experiences and perceptions of depression were a) anger and negativity, b) depression is weakness, c) invisible depression, d) being strong and going on and e) our depression is different. With regard to societal consequences, participants overwhelmingly reported that they believed that no one cared about the depression experiences of young Black men. Findings from this study suggest the need for research to develop screening and assessment tools that accurately measure depression in this population. Findings also have implications for clinicians who identify and initiate ongoing therapeutic relationships with young Black men with depression. Mental health promotion programs that target the specific needs of this population are also warrantedAbstract -- List of tables -- Acknowledgements -- Introduction -- Literature review -- Methodology -- Study manuscript -- Appendix -- Participant interest notecard -- Interview form -- Depression study information form -- Demographic form -- Receipts -- Transcription confidentiality form -- UMKC IRB authorization -- Letter of support -- Reference

Online users of child sexual exploitation material (CSEM)

Recent years have seen a substantial increase in the number of individuals engaging in offences relating to the online use of child sexual exploitation material (CSEM), to the point that UK police forces have stated that they “cannot arrest their way out of the problem”. Current movements are shifting the focus towards primary and secondary prevention efforts through public health campaigns, yet our knowledge of this typology of offending still remains somewhat limited. As such, a research project has been established to explore some of the remaining unanswered questions, for example, what are the motivations behind this type of offence? This poster will showcase the research project, exploring demographic and psychological factors associated with CSEM offending. The investigation includes both detected and “undetected” users of CSEM recruited internationally from the UK’s justice system and Germany’s Prevention Project Dunkelfeld (treatment programme for people attracted to children and/ or adolescents). Data is based on self-report questionnaires assessing personality, sexuality and general wellbeing, early life experiences, sexual and relationship history, education and employment, and details of offending behaviour. The poster will present implications for the prevention, assessment, and management of individuals (including those at risk of) accessing CSEM

Strength-based approaches to online child sexual abuse: Using self-management strategies to enhance desistance behaviour in users of child sexual exploitation material

© 2017, © Emerald Publishing Limited. Purpose: Increasing numbers of convictions for the use of child sexual exploitation material (CSEM) call for enhanced measures to prevent this type of offending. Strength-based approaches such as the good lives model have made significant contributions to the management of offenders who have sexually abused against children. The paper aims to discuss these issues. Design/methodology/approach: The present study explored the application of these models to the rehabilitation and desistance behaviour of CSEM users, based on a thematic analysis of the self-managed desistance strategies employed by 26 offenders. Findings: The findings confirmed the value of strength-based approaches in understanding self-management strategies used to enhance desistance behaviour in CSEM users. Research limitations/implications: The empirical and theoretical findings were then combined into a conceptual framework aimed to enhance preventative efforts and interventions targeted at undetected CSEM users. Originality/value: This paper provides the first conceptual and empirical model of prevention and desistance behaviour specific to CSEM offending

I C: Slavery and Human Trafficking

We will be discussing the issue of human trafficking from the 4 different disciplines of 1) Communication Technologies, 2) Business and the Economy, 3) Nursing and Healthcare, and 4) Psychology

Zephyr: The Thirteenth Issue

This is the thirteenth issue of Zephyr, the University of New England\u27s journal of creative expression. Since 2000, Zephyr has published original drawings, paintings, photography, prose, and verse created by current and former members of the University community. Zephyr\u27s Editorial Board is made up exclusively of matriculating students.https://dune.une.edu/zephyr/1012/thumbnail.jp

The effect of statins on muscle symptoms in primary care:the StatinWISE series of 200 N-of-1 RCTs

Background: Uncertainty persists about whether or not statins cause symptomatic muscle adverse effects (e.g. pain, stiffness and weakness) in the absence of severe myositis.Objectives: To establish the effect of statins on all muscle symptoms, and the effect of statins on muscle symptoms that are perceived to be statin related.Design: A series of 200 double-blinded N-of-1 trials.Setting: Participants were recruited from 50 general practices in England and Wales.Participants: Patients who were considering discontinuing statin use and those who had discontinued statin use in the last 3 years because of perceived muscle symptoms.Interventions: Participants were randomised to a sequence of six 2-month treatment periods during which they received 20 mg of atorvastatin daily or a matched placebo.Main outcome measures: The primary outcome was self-reported muscle symptoms rated using a visual analogue scale on the last week of each treatment period. Secondary outcomes included the participant's belief about the cause of their muscle symptoms, the site of muscle symptoms, how the muscle symptoms affected the participant, any other symptoms they experienced, adherence to medication, the participant's decision about statin treatment following the trial, and whether or not they found their own trial result helpful.Results: A total of 151 out of 200 (75.5%) randomised participants provided one or more visual analogue scale measurements in a placebo period and one or more measurements in a statin period, and were included in the primary analysis. There was no evidence of a difference in muscle symptom scores between statin and placebo periods (mean difference statin minus placebo -0.11, 95% confidence interval -0.36 to 0.14; p = 0.398). Withdrawals, adherence and missing data were similar during the statin periods and the placebo periods.Conclusions: Among people who previously reported severe muscle symptoms while taking statins, this series of randomised N-of-1 trials found no overall effect of statins on muscle symptoms compared with the placebo. The slight difference in withdrawals due to muscle symptoms suggests that statins may contribute to symptoms in a small number of patients. The results are generalisable to patients who are considering discontinuing or have already discontinued statins because of muscle symptoms, and who are willing to re-challenge or participate in their own N-of-1 trial.Future work: We recommend that additional statins and doses are explored using N-of-1 trials. More broadly, N-of-1 trials present a useful tool for exploring transient symptoms with other medications.Limitations: This study used 20-mg doses of atorvastatin only. Furthermore, a dropout rate of 43% was observed, but this was accounted for in the power calculations.Trial registration: Current Controlled Trials ISRCTN30952488 and EudraCT 2016-000141-31.</p

The Grizzly, April 13, 2006

Relay a Success • New Healthcare Scholarship Available • Lurking Beneath the Skin: Scabies Infection • Day of Museums • Shopping with Eco-labels • Airband a Hit • Opinions: Drawing the Line: Moral Predicament of Abortion, Part II • Importance of CoSA: A Message • Bears Battle Back • Real Deal on Steroidshttps://digitalcommons.ursinus.edu/grizzlynews/1712/thumbnail.jp

Statin treatment and muscle symptoms:series of randomised, placebo controlled n-of-1 trials

OBJECTIVE: To establish the effect of statins on muscle symptoms in people who had previously reported muscle symptoms when taking statins. DESIGN: Series of randomised, placebo controlled n-of-1 trials. SETTING: Primary care across 50 sites in the United Kingdom, December 2016 to April 2018. PARTICIPANTS: 200 participants who had recently stopped or were considering stopping treatment with statins because of muscle symptoms. INTERVENTIONS: Participants were randomised to a sequence of six double blinded treatment periods (two months each) of atorvastatin 20 mg daily or placebo. MAIN OUTCOME MEASURES: At the end of each treatment period, participants rated their muscle symptoms on a visual analogue scale (0-10). The primary analysis compared symptom scores in the statin and placebo periods. RESULTS: 151 participants provided symptoms scores for at least one statin period and one placebo period and were included in the primary analysis. Overall, no difference in muscle symptom scores was found between the statin and placebo periods (mean difference statin minus placebo -0.11, 95% confidence interval -0.36 to 0.14; P=0.40)). Withdrawals because of intolerable muscle symptoms were 18 participants (9%) during a statin period and 13 (7%) during a placebo period. Two thirds of those completing the trial reported restarting long term treatment with statins. CONCLUSIONS: No overall effect of atorvastatin 20 mg on muscle symptoms compared with placebo was found in participants who had previously reported severe muscle symptoms when taking statins. Most people completing the trial intended to restart treatment with statins. N-of-1 trials can assess drug effects at the group level and guide individual treatment. TRIAL REGISTRATION: ISRCTN30952488, EUDRACT 2016-000141-31, NCT02781064

The Grizzly, March 2, 2006

Omega Chi Hosts Red Cross Blood Drive • Alumna of Sigma Gamma Rho Honored with Stamp • Georgetown Professor Speaks About Abortion • Ursinus Hosts Job and Internship Fair • Introducing the IUD • Centre Pompidou: Modern Art • Breaking Stereotypes • WVOU Spotlight: Bloc Party • Opinions: Red Cross Guidelines Demonstrate Questionable Requirements • Letter to the Editor • Is the Juice Worth the Squeeze?https://digitalcommons.ursinus.edu/grizzlynews/1708/thumbnail.jp